JP2014500322A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014500322A5 JP2014500322A5 JP2013546262A JP2013546262A JP2014500322A5 JP 2014500322 A5 JP2014500322 A5 JP 2014500322A5 JP 2013546262 A JP2013546262 A JP 2013546262A JP 2013546262 A JP2013546262 A JP 2013546262A JP 2014500322 A5 JP2014500322 A5 JP 2014500322A5
- Authority
- JP
- Japan
- Prior art keywords
- benzofuran
- cyclopropyl
- fluorophenyl
- methanesulfonamide
- imidazol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims 99
- -1 wherein Chemical group 0.000 claims 89
- 125000003037 imidazol-2-yl group Chemical group [H]N1C([*])=NC([H])=C1[H] 0.000 claims 51
- 229910052736 halogen Inorganic materials 0.000 claims 47
- 150000002367 halogens Chemical class 0.000 claims 47
- 150000001875 compounds Chemical class 0.000 claims 43
- 229910052757 nitrogen Inorganic materials 0.000 claims 37
- 229910052739 hydrogen Inorganic materials 0.000 claims 33
- 239000001257 hydrogen Substances 0.000 claims 33
- 125000001424 substituent group Chemical group 0.000 claims 30
- 150000002431 hydrogen Chemical class 0.000 claims 24
- 229910052760 oxygen Inorganic materials 0.000 claims 24
- 150000003839 salts Chemical class 0.000 claims 24
- 125000004043 oxo group Chemical group O=* 0.000 claims 23
- 229910052717 sulfur Inorganic materials 0.000 claims 22
- 125000000217 alkyl group Chemical group 0.000 claims 20
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 18
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 17
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 17
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims 16
- HNQIVZYLYMDVSB-UHFFFAOYSA-N methanesulfonimidic acid Chemical compound CS(N)(=O)=O HNQIVZYLYMDVSB-UHFFFAOYSA-N 0.000 claims 13
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims 12
- 125000001188 haloalkyl group Chemical group 0.000 claims 11
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 11
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 claims 10
- 125000006374 C2-C10 alkenyl group Chemical group 0.000 claims 10
- 125000005865 C2-C10alkynyl group Chemical group 0.000 claims 10
- 125000003118 aryl group Chemical group 0.000 claims 10
- 125000000623 heterocyclic group Chemical group 0.000 claims 10
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 10
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims 9
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 9
- 125000004093 cyano group Chemical group *C#N 0.000 claims 9
- 125000006163 5-membered heteroaryl group Chemical group 0.000 claims 8
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 8
- 239000003814 drug Substances 0.000 claims 7
- 125000001313 C5-C10 heteroaryl group Chemical group 0.000 claims 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 6
- 125000000262 haloalkenyl group Chemical group 0.000 claims 6
- 125000000232 haloalkynyl group Chemical group 0.000 claims 6
- 125000001072 heteroaryl group Chemical group 0.000 claims 5
- 229940124597 therapeutic agent Drugs 0.000 claims 5
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 claims 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims 4
- 238000000034 method Methods 0.000 claims 4
- 238000002360 preparation method Methods 0.000 claims 4
- 229920002477 rna polymer Polymers 0.000 claims 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims 3
- 241000700605 Viruses Species 0.000 claims 3
- 150000001408 amides Chemical class 0.000 claims 3
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 3
- 208000015181 infectious disease Diseases 0.000 claims 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 3
- IBYHHJPAARCAIE-UHFFFAOYSA-N 1-bromo-2-chloroethane Chemical compound ClCCBr IBYHHJPAARCAIE-UHFFFAOYSA-N 0.000 claims 2
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 claims 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims 2
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 claims 2
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 claims 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims 2
- 125000004450 alkenylene group Chemical group 0.000 claims 2
- 125000004419 alkynylene group Chemical group 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 239000002808 molecular sieve Substances 0.000 claims 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims 2
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 claims 2
- 238000006467 substitution reaction Methods 0.000 claims 2
- 125000006832 (C1-C10) alkylene group Chemical group 0.000 claims 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims 1
- FZLBIQMUICKRDK-UHFFFAOYSA-N 2-[6-(2,5-dimethylpyrrol-1-yl)-2-phenyl-1-benzofuran-3-yl]-1h-imidazole Chemical compound CC1=CC=C(C)N1C1=CC=C(C(C=2NC=CN=2)=C(O2)C=3C=CC=CC=3)C2=C1 FZLBIQMUICKRDK-UHFFFAOYSA-N 0.000 claims 1
- NDRHOYIKEHEWAN-UHFFFAOYSA-N 3-[3-(1h-imidazol-2-yl)-2-(4-methoxyphenyl)pyrazolo[1,5-a]pyridin-5-yl]-4-methyl-n-(1-phenylcyclopropyl)benzamide Chemical compound C1=CC(OC)=CC=C1C1=NN(C=CC(=C2)C=3C(=CC=C(C=3)C(=O)NC3(CC3)C=3C=CC=CC=3)C)C2=C1C1=NC=CN1 NDRHOYIKEHEWAN-UHFFFAOYSA-N 0.000 claims 1
- AVUBUQNTEAIQGH-UHFFFAOYSA-N 3-[[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]-methylsulfonylamino]-n-methylpropane-1-sulfonamide Chemical compound C1=2C=C(C3CC3)C(N(CCCS(=O)(=O)NC)S(C)(=O)=O)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NC=CN1 AVUBUQNTEAIQGH-UHFFFAOYSA-N 0.000 claims 1
- CRDBBGWKFXLNJC-UHFFFAOYSA-N 4-[[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]-methylsulfonylamino]-n'-hydroxybutanimidamide Chemical compound C1=2C=C(C3CC3)C(N(CCC\C(N)=N\O)S(=O)(=O)C)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NC=CN1 CRDBBGWKFXLNJC-UHFFFAOYSA-N 0.000 claims 1
- FSMIULIYKCFWGE-UHFFFAOYSA-N 4-[[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]-methylsulfonylamino]-n-methylbutanamide Chemical compound C1=2C=C(C3CC3)C(N(CCCC(=O)NC)S(C)(=O)=O)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NC=CN1 FSMIULIYKCFWGE-UHFFFAOYSA-N 0.000 claims 1
- ZJKUSFXWFDSAGW-UHFFFAOYSA-N 4-[[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]-methylsulfonylamino]butanoic acid Chemical compound C1=2C=C(C3CC3)C(N(CCCC(O)=O)S(=O)(=O)C)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NC=CN1 ZJKUSFXWFDSAGW-UHFFFAOYSA-N 0.000 claims 1
- UPJUAAGYTXKNSD-UHFFFAOYSA-N 4-[[5-cyclopropyl-3-(2,5-dihydro-1,2,4-oxadiazol-3-yl)-2-(4-fluorophenyl)-1-benzofuran-6-yl]-methylsulfonylamino]butanoic acid Chemical compound C1=2C=C(C3CC3)C(N(CCCC(O)=O)S(=O)(=O)C)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NOCN1 UPJUAAGYTXKNSD-UHFFFAOYSA-N 0.000 claims 1
- WXPPBIIVFIIMIP-UHFFFAOYSA-N 4-[[5-cyclopropyl-3-(5,6-dihydro-2h-1,2,4-oxadiazin-3-yl)-2-(4-fluorophenyl)-1-benzofuran-6-yl]-methylsulfonylamino]-n'-hydroxybutanimidamide Chemical compound C1=2C=C(C3CC3)C(N(CCCC(=N)NO)S(=O)(=O)C)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NOCCN1 WXPPBIIVFIIMIP-UHFFFAOYSA-N 0.000 claims 1
- UXMZTYOMHATDAW-UHFFFAOYSA-N 4-[[5-cyclopropyl-3-(5,6-dihydro-2h-1,2,4-oxadiazin-3-yl)-2-(4-fluorophenyl)-1-benzofuran-6-yl]-methylsulfonylamino]butanoic acid Chemical compound C1=2C=C(C3CC3)C(N(CCCC(O)=O)S(=O)(=O)C)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NOCCN1 UXMZTYOMHATDAW-UHFFFAOYSA-N 0.000 claims 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims 1
- 125000002373 5 membered heterocyclic group Chemical group 0.000 claims 1
- LBKRPEDEYNCHAH-UHFFFAOYSA-N 5-[[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]-methylsulfonylamino]pentanoic acid Chemical compound C1=2C=C(C3CC3)C(N(CCCCC(O)=O)S(=O)(=O)C)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NC=CN1 LBKRPEDEYNCHAH-UHFFFAOYSA-N 0.000 claims 1
- 125000004938 5-pyridyl group Chemical group N1=CC=CC(=C1)* 0.000 claims 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-M Aminoacetate Chemical compound NCC([O-])=O DHMQDGOQFOQNFH-UHFFFAOYSA-M 0.000 claims 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 claims 1
- 229910003849 O-Si Inorganic materials 0.000 claims 1
- 229910003872 O—Si Inorganic materials 0.000 claims 1
- ZBIKORITPGTTGI-UHFFFAOYSA-N [acetyloxy(phenyl)-$l^{3}-iodanyl] acetate Chemical compound CC(=O)OI(OC(C)=O)C1=CC=CC=C1 ZBIKORITPGTTGI-UHFFFAOYSA-N 0.000 claims 1
- PGMYKACGEOXYJE-UHFFFAOYSA-N anhydrous amyl acetate Natural products CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 claims 1
- DNSISZSEWVHGLH-UHFFFAOYSA-N butanamide Chemical compound CCCC(N)=O DNSISZSEWVHGLH-UHFFFAOYSA-N 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 claims 1
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 1
- BEBCJVAWIBVWNZ-UHFFFAOYSA-N glycinamide Chemical compound NCC(N)=O BEBCJVAWIBVWNZ-UHFFFAOYSA-N 0.000 claims 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- RCBVKBFIWMOMHF-UHFFFAOYSA-L hydroxy-(hydroxy(dioxo)chromio)oxy-dioxochromium;pyridine Chemical compound C1=CC=NC=C1.C1=CC=NC=C1.O[Cr](=O)(=O)O[Cr](O)(=O)=O RCBVKBFIWMOMHF-UHFFFAOYSA-L 0.000 claims 1
- 125000004531 indol-5-yl group Chemical group [H]N1C([H])=C([H])C2=C([H])C(*)=C([H])C([H])=C12 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 claims 1
- 239000012280 lithium aluminium hydride Substances 0.000 claims 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 125000002912 morpholin-4-ylsulfonyl group Chemical group O1C([H])([H])C([H])([H])N(S(=O)(=O)[*])C([H])([H])C1([H])[H] 0.000 claims 1
- MYLUPBXSPOJRPM-UHFFFAOYSA-N n-(2-aminoethyl)-n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]methanesulfonamide Chemical compound C1=2C=C(C3CC3)C(N(CCN)S(=O)(=O)C)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NC=CN1 MYLUPBXSPOJRPM-UHFFFAOYSA-N 0.000 claims 1
- ZOFPMEAEPQWWJW-UHFFFAOYSA-N n-(2-cyclohexylethyl)-n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]methanesulfonamide Chemical compound C=1C=2OC(C=3C=CC(F)=CC=3)=C(C=3NC=CN=3)C=2C=C(C2CC2)C=1N(S(=O)(=O)C)CCC1CCCCC1 ZOFPMEAEPQWWJW-UHFFFAOYSA-N 0.000 claims 1
- UMDKPEZPAXCNNB-UHFFFAOYSA-N n-(3-aminopropyl)-n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]methanesulfonamide Chemical compound C1=2C=C(C3CC3)C(N(CCCN)S(=O)(=O)C)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NC=CN1 UMDKPEZPAXCNNB-UHFFFAOYSA-N 0.000 claims 1
- RQFLAZZZBNMSGJ-UHFFFAOYSA-N n-(3-cyanopropyl)-n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]methanesulfonamide Chemical compound C1=2C=C(C3CC3)C(N(CCCC#N)S(=O)(=O)C)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NC=CN1 RQFLAZZZBNMSGJ-UHFFFAOYSA-N 0.000 claims 1
- CAUQQOUEDCRKLJ-UHFFFAOYSA-N n-(cyanomethyl)-n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]methanesulfonamide Chemical compound C1=2C=C(C3CC3)C(N(CC#N)S(=O)(=O)C)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NC=CN1 CAUQQOUEDCRKLJ-UHFFFAOYSA-N 0.000 claims 1
- JHCPWQHANUANAK-UHFFFAOYSA-N n-(cyclohexylmethyl)-n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]methanesulfonamide Chemical compound C=1C=2OC(C=3C=CC(F)=CC=3)=C(C=3NC=CN=3)C=2C=C(C2CC2)C=1N(S(=O)(=O)C)CC1CCCCC1 JHCPWQHANUANAK-UHFFFAOYSA-N 0.000 claims 1
- KWGYYWZXXLUCFC-UHFFFAOYSA-N n-(cyclopentylmethyl)-n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]methanesulfonamide Chemical compound C=1C=2OC(C=3C=CC(F)=CC=3)=C(C=3NC=CN=3)C=2C=C(C2CC2)C=1N(S(=O)(=O)C)CC1CCCC1 KWGYYWZXXLUCFC-UHFFFAOYSA-N 0.000 claims 1
- FUWRTEXLTFZWGF-UHFFFAOYSA-N n-[(2-bromo-1,3-thiazol-5-yl)methyl]-n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]methanesulfonamide Chemical compound C=1C=2OC(C=3C=CC(F)=CC=3)=C(C=3NC=CN=3)C=2C=C(C2CC2)C=1N(S(=O)(=O)C)CC1=CN=C(Br)S1 FUWRTEXLTFZWGF-UHFFFAOYSA-N 0.000 claims 1
- BFGJMDZSTJICKA-UHFFFAOYSA-N n-[2-(4-anilinophenyl)-5-cyclopropyl-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]-n-(3-methylbutyl)methanesulfonamide Chemical compound C1=2C=C(C3CC3)C(N(CCC(C)C)S(C)(=O)=O)=CC=2OC(C=2C=CC(NC=3C=CC=CC=3)=CC=2)=C1C1=NC=CN1 BFGJMDZSTJICKA-UHFFFAOYSA-N 0.000 claims 1
- RIKIJEFEHGUSIB-UHFFFAOYSA-N n-[2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-5-propan-2-yloxy-1-benzofuran-6-yl]-n-[(4-methoxyphenyl)methyl]methanesulfonamide Chemical compound C1=CC(OC)=CC=C1CN(S(C)(=O)=O)C(C(=C1)OC(C)C)=CC2=C1C(C=1NC=CN=1)=C(C=1C=CC(F)=CC=1)O2 RIKIJEFEHGUSIB-UHFFFAOYSA-N 0.000 claims 1
- CSOKSSVKVATETF-UHFFFAOYSA-N n-[3-(1h-imidazol-2-yl)-2-phenyl-1-benzofuran-6-yl]-n-(1-phenylethyl)methanesulfonamide Chemical compound C=1C=CC=CC=1C(C)N(S(C)(=O)=O)C(C=C1OC=2C=3C=CC=CC=3)=CC=C1C=2C1=NC=CN1 CSOKSSVKVATETF-UHFFFAOYSA-N 0.000 claims 1
- XAKADMFPZSTBFD-UHFFFAOYSA-N n-[3-(5-chloro-1h-imidazol-2-yl)-5-cyclopropyl-2-(4-fluorophenyl)-1-benzofuran-6-yl]methanesulfonamide Chemical compound C1=2C=C(C3CC3)C(NS(=O)(=O)C)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NC(Cl)=CN1 XAKADMFPZSTBFD-UHFFFAOYSA-N 0.000 claims 1
- YJAKIGWKNQMVJC-UHFFFAOYSA-N n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]-n-(2,3-dihydroxy-3-methylbutyl)methanesulfonamide Chemical compound C1=2C=C(C3CC3)C(N(CC(O)C(C)(O)C)S(C)(=O)=O)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NC=CN1 YJAKIGWKNQMVJC-UHFFFAOYSA-N 0.000 claims 1
- AEVUGNFPTSENSF-UHFFFAOYSA-N n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]-n-(2-hydroxyethyl)methanesulfonamide Chemical compound C1=2C=C(C3CC3)C(N(CCO)S(=O)(=O)C)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NC=CN1 AEVUGNFPTSENSF-UHFFFAOYSA-N 0.000 claims 1
- MARQOJTUVDMPNG-UHFFFAOYSA-N n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]-n-(2-hydroxypropyl)methanesulfonamide Chemical compound C1=2C=C(C3CC3)C(N(CC(O)C)S(C)(=O)=O)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NC=CN1 MARQOJTUVDMPNG-UHFFFAOYSA-N 0.000 claims 1
- WTCMXJSRGNXMOL-UHFFFAOYSA-N n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]-n-(2-methoxyethyl)methanesulfonamide Chemical compound C1=2C=C(C3CC3)C(N(CCOC)S(C)(=O)=O)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NC=CN1 WTCMXJSRGNXMOL-UHFFFAOYSA-N 0.000 claims 1
- USZWJLKTQGAXCJ-UHFFFAOYSA-N n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]-n-(2-methylpropyl)methanesulfonamide Chemical compound C1=2C=C(C3CC3)C(N(CC(C)C)S(C)(=O)=O)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NC=CN1 USZWJLKTQGAXCJ-UHFFFAOYSA-N 0.000 claims 1
- SUGGGKHFWAZCSZ-UHFFFAOYSA-N n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]-n-(2-phenoxyethyl)methanesulfonamide Chemical compound C=1C=2OC(C=3C=CC(F)=CC=3)=C(C=3NC=CN=3)C=2C=C(C2CC2)C=1N(S(=O)(=O)C)CCOC1=CC=CC=C1 SUGGGKHFWAZCSZ-UHFFFAOYSA-N 0.000 claims 1
- FYAZBEQVXGGLTG-UHFFFAOYSA-N n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]-n-(2-phenylethyl)methanesulfonamide Chemical compound C=1C=2OC(C=3C=CC(F)=CC=3)=C(C=3NC=CN=3)C=2C=C(C2CC2)C=1N(S(=O)(=O)C)CCC1=CC=CC=C1 FYAZBEQVXGGLTG-UHFFFAOYSA-N 0.000 claims 1
- NJKJZDVEQNVQEJ-UHFFFAOYSA-N n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]-n-(3,4-dihydroxy-4-methylpentyl)methanesulfonamide Chemical compound C1=2C=C(C3CC3)C(N(CCC(O)C(C)(O)C)S(C)(=O)=O)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NC=CN1 NJKJZDVEQNVQEJ-UHFFFAOYSA-N 0.000 claims 1
- OGINSDBPVVDQLB-UHFFFAOYSA-N n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]-n-(3-fluoropropyl)methanesulfonamide Chemical compound C1=2C=C(C3CC3)C(N(CCCF)S(=O)(=O)C)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NC=CN1 OGINSDBPVVDQLB-UHFFFAOYSA-N 0.000 claims 1
- JDCGTMFUHRPIEZ-UHFFFAOYSA-N n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]-n-(3-hydroxypropyl)methanesulfonamide Chemical compound C1=2C=C(C3CC3)C(N(CCCO)S(=O)(=O)C)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NC=CN1 JDCGTMFUHRPIEZ-UHFFFAOYSA-N 0.000 claims 1
- FFWZIPZHTOFSKI-UHFFFAOYSA-N n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]-n-(3-methoxypropyl)methanesulfonamide Chemical compound C1=2C=C(C3CC3)C(N(CCCOC)S(C)(=O)=O)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NC=CN1 FFWZIPZHTOFSKI-UHFFFAOYSA-N 0.000 claims 1
- WBTXZGJHROTQJZ-UHFFFAOYSA-N n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]-n-(3-methylbutyl)methanesulfonamide Chemical compound C1=2C=C(C3CC3)C(N(CCC(C)C)S(C)(=O)=O)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NC=CN1 WBTXZGJHROTQJZ-UHFFFAOYSA-N 0.000 claims 1
- SRVBGNCNJQZSOR-UHFFFAOYSA-N n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]-n-(3-phenoxypropyl)methanesulfonamide Chemical compound C=1C=2OC(C=3C=CC(F)=CC=3)=C(C=3NC=CN=3)C=2C=C(C2CC2)C=1N(S(=O)(=O)C)CCCOC1=CC=CC=C1 SRVBGNCNJQZSOR-UHFFFAOYSA-N 0.000 claims 1
- ATHWWMWRXIYCJT-UHFFFAOYSA-N n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]-n-(3-phenylpropyl)methanesulfonamide Chemical compound C=1C=2OC(C=3C=CC(F)=CC=3)=C(C=3NC=CN=3)C=2C=C(C2CC2)C=1N(S(=O)(=O)C)CCCC1=CC=CC=C1 ATHWWMWRXIYCJT-UHFFFAOYSA-N 0.000 claims 1
- SMXUVNFVRNVGRS-UHFFFAOYSA-N n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]-n-(4,4,4-trifluorobutyl)methanesulfonamide Chemical compound C1=2C=C(C3CC3)C(N(CCCC(F)(F)F)S(=O)(=O)C)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NC=CN1 SMXUVNFVRNVGRS-UHFFFAOYSA-N 0.000 claims 1
- RFVBERVLAXNQLY-UHFFFAOYSA-N n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]-n-(4-fluorobutyl)methanesulfonamide Chemical compound C1=2C=C(C3CC3)C(N(CCCCF)S(=O)(=O)C)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NC=CN1 RFVBERVLAXNQLY-UHFFFAOYSA-N 0.000 claims 1
- XXPKRPDUTCNAAA-UHFFFAOYSA-N n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]-n-(4-hydroxy-4-methylpentyl)methanesulfonamide Chemical compound C1=2C=C(C3CC3)C(N(CCCC(C)(O)C)S(C)(=O)=O)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NC=CN1 XXPKRPDUTCNAAA-UHFFFAOYSA-N 0.000 claims 1
- SSUCZGSPTGOPLJ-UHFFFAOYSA-N n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]-n-(4-hydroxybutyl)methanesulfonamide Chemical compound C1=2C=C(C3CC3)C(N(CCCCO)S(=O)(=O)C)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NC=CN1 SSUCZGSPTGOPLJ-UHFFFAOYSA-N 0.000 claims 1
- BGKHGXOEBKWUNF-UHFFFAOYSA-N n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]-n-(4-hydroxypentyl)methanesulfonamide Chemical compound C1=2C=C(C3CC3)C(N(CCCC(O)C)S(C)(=O)=O)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NC=CN1 BGKHGXOEBKWUNF-UHFFFAOYSA-N 0.000 claims 1
- HDWQKAOYXPTNSQ-UHFFFAOYSA-N n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]-n-(4-methylpentyl)methanesulfonamide Chemical compound C1=2C=C(C3CC3)C(N(CCCC(C)C)S(C)(=O)=O)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NC=CN1 HDWQKAOYXPTNSQ-UHFFFAOYSA-N 0.000 claims 1
- RYZAYDNSPWCTNX-UHFFFAOYSA-N n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]-n-(4-oxopentyl)methanesulfonamide Chemical compound C1=2C=C(C3CC3)C(N(CCCC(=O)C)S(C)(=O)=O)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NC=CN1 RYZAYDNSPWCTNX-UHFFFAOYSA-N 0.000 claims 1
- SFCJAZJTGHYQPP-UHFFFAOYSA-N n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]-n-(5-hydroxypentyl)methanesulfonamide Chemical compound C1=2C=C(C3CC3)C(N(CCCCCO)S(=O)(=O)C)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NC=CN1 SFCJAZJTGHYQPP-UHFFFAOYSA-N 0.000 claims 1
- SQAZDWGEJDDDTB-UHFFFAOYSA-N n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]-n-(5-oxohexyl)methanesulfonamide Chemical compound C1=2C=C(C3CC3)C(N(CCCCC(=O)C)S(C)(=O)=O)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NC=CN1 SQAZDWGEJDDDTB-UHFFFAOYSA-N 0.000 claims 1
- SLJIZNNCCZAFOA-UHFFFAOYSA-N n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]-n-(pyrrolidin-3-ylmethyl)methanesulfonamide Chemical compound C=1C=2OC(C=3C=CC(F)=CC=3)=C(C=3NC=CN=3)C=2C=C(C2CC2)C=1N(S(=O)(=O)C)CC1CCNC1 SLJIZNNCCZAFOA-UHFFFAOYSA-N 0.000 claims 1
- UUIXMCKMBQDEGT-UHFFFAOYSA-N n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]-n-[(2,2-difluorocyclopropyl)methyl]methanesulfonamide Chemical compound C=1C=2OC(C=3C=CC(F)=CC=3)=C(C=3NC=CN=3)C=2C=C(C2CC2)C=1N(S(=O)(=O)C)CC1CC1(F)F UUIXMCKMBQDEGT-UHFFFAOYSA-N 0.000 claims 1
- FSKFEYMEARFUBH-UHFFFAOYSA-N n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]-n-[2-(4-methyl-1,3-thiazol-5-yl)ethyl]methanesulfonamide Chemical compound N1=CSC(CCN(C=2C(=CC=3C(C=4NC=CN=4)=C(OC=3C=2)C=2C=CC(F)=CC=2)C2CC2)S(C)(=O)=O)=C1C FSKFEYMEARFUBH-UHFFFAOYSA-N 0.000 claims 1
- JGIQHWHAHQXFQS-UHFFFAOYSA-N n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]-n-[3-(2-oxo-3h-1,3,4-oxadiazol-5-yl)propyl]methanesulfonamide Chemical compound C=1C=2OC(C=3C=CC(F)=CC=3)=C(C=3NC=CN=3)C=2C=C(C2CC2)C=1N(S(=O)(=O)C)CCCC1=NNC(=O)O1 JGIQHWHAHQXFQS-UHFFFAOYSA-N 0.000 claims 1
- SPJBBRMMOHSELT-UHFFFAOYSA-N n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]-n-[3-(5-sulfanylidene-2h-1,2,4-oxadiazol-3-yl)propyl]methanesulfonamide Chemical compound C=1C=2OC(C=3C=CC(F)=CC=3)=C(C=3NC=CN=3)C=2C=C(C2CC2)C=1N(S(=O)(=O)C)CCCC1=NOC(=S)N1 SPJBBRMMOHSELT-UHFFFAOYSA-N 0.000 claims 1
- OQIOMIJFSPSIMM-UHFFFAOYSA-N n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]-n-[3-(dimethylamino)propyl]methanesulfonamide Chemical compound C1=2C=C(C3CC3)C(N(CCCN(C)C)S(C)(=O)=O)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NC=CN1 OQIOMIJFSPSIMM-UHFFFAOYSA-N 0.000 claims 1
- IGJPDXWAHQFJSB-UHFFFAOYSA-N n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]-n-ethylmethanesulfonamide Chemical compound C1=2C=C(C3CC3)C(N(CC)S(C)(=O)=O)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NC=CN1 IGJPDXWAHQFJSB-UHFFFAOYSA-N 0.000 claims 1
- OSGZLHOJYXURRD-UHFFFAOYSA-N n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]-n-hexylmethanesulfonamide Chemical compound C1=2C=C(C3CC3)C(N(CCCCCC)S(C)(=O)=O)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NC=CN1 OSGZLHOJYXURRD-UHFFFAOYSA-N 0.000 claims 1
- WIGBTTBIFRAVHJ-UHFFFAOYSA-N n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]-n-pentylmethanesulfonamide Chemical compound C1=2C=C(C3CC3)C(N(CCCCC)S(C)(=O)=O)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NC=CN1 WIGBTTBIFRAVHJ-UHFFFAOYSA-N 0.000 claims 1
- WECBDEKUMHMKSI-UHFFFAOYSA-N n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]-n-propan-2-ylmethanesulfonamide Chemical compound C1=2C=C(C3CC3)C(N(C(C)C)S(C)(=O)=O)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NC=CN1 WECBDEKUMHMKSI-UHFFFAOYSA-N 0.000 claims 1
- FVLAVGSGZRZWOC-UHFFFAOYSA-N n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]-n-propylmethanesulfonamide Chemical compound C1=2C=C(C3CC3)C(N(CCC)S(C)(=O)=O)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NC=CN1 FVLAVGSGZRZWOC-UHFFFAOYSA-N 0.000 claims 1
- VOWIEJMSDWCGRN-UHFFFAOYSA-N n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)-1-benzofuran-6-yl]methanesulfonamide Chemical compound C1=2C=C(C3CC3)C(NS(=O)(=O)C)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NC=CN1 VOWIEJMSDWCGRN-UHFFFAOYSA-N 0.000 claims 1
- DJAPJDMEXJOPEE-UHFFFAOYSA-N n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(1h-imidazol-2-yl)pyrazolo[1,5-a]pyridin-6-yl]-n-(3-methylbutyl)methanesulfonamide Chemical compound C=12C=C(C3CC3)C(N(CCC(C)C)S(C)(=O)=O)=CN2N=C(C=2C=CC(F)=CC=2)C=1C1=NC=CN1 DJAPJDMEXJOPEE-UHFFFAOYSA-N 0.000 claims 1
- SKJCACLBRGINKA-UHFFFAOYSA-N n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(5-methyl-1h-imidazol-2-yl)-1-benzofuran-6-yl]-n-(3-methylbutyl)methanesulfonamide Chemical compound C1=2C=C(C3CC3)C(N(CCC(C)C)S(C)(=O)=O)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NC=C(C)N1 SKJCACLBRGINKA-UHFFFAOYSA-N 0.000 claims 1
- AYUCBEMEXICJNK-UHFFFAOYSA-N n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(5-methyl-1h-imidazol-2-yl)-1-benzofuran-6-yl]methanesulfonamide Chemical compound CC1=CNC(C=2C3=CC(=C(NS(C)(=O)=O)C=C3OC=2C=2C=CC(F)=CC=2)C2CC2)=N1 AYUCBEMEXICJNK-UHFFFAOYSA-N 0.000 claims 1
- YDFSWPQAEKSXDM-UHFFFAOYSA-N n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(5-methyl-2,5-dihydro-1,2,4-oxadiazol-3-yl)-1-benzofuran-6-yl]-n-(2-methylsulfonylethyl)methanesulfonamide Chemical compound O1C(C)NC(C=2C3=CC(=C(N(CCS(C)(=O)=O)S(C)(=O)=O)C=C3OC=2C=2C=CC(F)=CC=2)C2CC2)=N1 YDFSWPQAEKSXDM-UHFFFAOYSA-N 0.000 claims 1
- SREOHEVRAFSAOK-UHFFFAOYSA-N n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(5-methyl-2,5-dihydro-1,2,4-oxadiazol-3-yl)-1-benzofuran-6-yl]-n-(3-methylbutyl)methanesulfonamide Chemical compound C1=2C=C(C3CC3)C(N(CCC(C)C)S(C)(=O)=O)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NOC(C)N1 SREOHEVRAFSAOK-UHFFFAOYSA-N 0.000 claims 1
- YODURFQCOQPRDK-UHFFFAOYSA-N n-[5-cyclopropyl-2-(4-fluorophenyl)-3-(5-methyl-2,5-dihydro-1,2,4-oxadiazol-3-yl)-1-benzofuran-6-yl]-n-(4-hydroxybutyl)methanesulfonamide Chemical compound O1C(C)NC(C=2C3=CC(=C(N(CCCCO)S(C)(=O)=O)C=C3OC=2C=2C=CC(F)=CC=2)C2CC2)=N1 YODURFQCOQPRDK-UHFFFAOYSA-N 0.000 claims 1
- QHRLKPUVTBIVER-UHFFFAOYSA-N n-[5-cyclopropyl-2-(4-fluorophenyl)-3-[5-(trifluoromethyl)-1h-imidazol-2-yl]-1-benzofuran-6-yl]-n-(3-methylbutyl)methanesulfonamide Chemical compound C1=2C=C(C3CC3)C(N(CCC(C)C)S(C)(=O)=O)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NC(C(F)(F)F)=CN1 QHRLKPUVTBIVER-UHFFFAOYSA-N 0.000 claims 1
- QBFFIVXKBCXRAB-UHFFFAOYSA-N n-[5-cyclopropyl-3-(2,5-dihydro-1,2,4-oxadiazol-3-yl)-2-(4-fluorophenyl)-1-benzofuran-6-yl]methanesulfonamide Chemical compound C1=2C=C(C3CC3)C(NS(=O)(=O)C)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NOCN1 QBFFIVXKBCXRAB-UHFFFAOYSA-N 0.000 claims 1
- NGOSMFDHKUYQAC-UHFFFAOYSA-N n-[5-cyclopropyl-3-(4,5-dibromo-1h-imidazol-2-yl)-2-(4-fluorophenyl)-1-benzofuran-6-yl]methanesulfonamide Chemical compound C1=2C=C(C3CC3)C(NS(=O)(=O)C)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NC(Br)=C(Br)N1 NGOSMFDHKUYQAC-UHFFFAOYSA-N 0.000 claims 1
- SQVLQZDJVOXZLV-UHFFFAOYSA-N n-[5-cyclopropyl-3-(4,5-dichloro-1h-imidazol-2-yl)-2-(4-fluorophenyl)-1-benzofuran-6-yl]methanesulfonamide Chemical compound C1=2C=C(C3CC3)C(NS(=O)(=O)C)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NC(Cl)=C(Cl)N1 SQVLQZDJVOXZLV-UHFFFAOYSA-N 0.000 claims 1
- JAQVEKXSCSPPRP-UHFFFAOYSA-N n-[5-cyclopropyl-3-(4,5-dimethyl-1h-imidazol-2-yl)-2-(4-fluorophenyl)-1-benzofuran-6-yl]methanesulfonamide Chemical compound N1C(C)=C(C)N=C1C1=C(C=2C=CC(F)=CC=2)OC2=CC(NS(C)(=O)=O)=C(C3CC3)C=C12 JAQVEKXSCSPPRP-UHFFFAOYSA-N 0.000 claims 1
- NTTKYEFMCAZEPQ-UHFFFAOYSA-N n-[5-cyclopropyl-3-(5,6-dihydro-2h-1,2,4-oxadiazin-3-yl)-2-(4-fluorophenyl)-1-benzofuran-6-yl]-n-(3-methylbutyl)methanesulfonamide Chemical compound C1=2C=C(C3CC3)C(N(CCC(C)C)S(C)(=O)=O)=CC=2OC(C=2C=CC(F)=CC=2)=C1C1=NOCCN1 NTTKYEFMCAZEPQ-UHFFFAOYSA-N 0.000 claims 1
- LKMFWTGTHWVJBJ-UHFFFAOYSA-N n-[[2-[3-(hydroxymethyl)phenyl]-1,3-thiazol-5-yl]methyl]-n-[3-(1h-imidazol-2-yl)-2-phenyl-1-benzofuran-6-yl]methanesulfonamide Chemical compound C=1C=C2C(C=3NC=CN=3)=C(C=3C=CC=CC=3)OC2=CC=1N(S(=O)(=O)C)CC(S1)=CN=C1C1=CC=CC(CO)=C1 LKMFWTGTHWVJBJ-UHFFFAOYSA-N 0.000 claims 1
- SNCMKFLBEGDPQR-UHFFFAOYSA-N n-[[2-bromo-4-(trifluoromethyl)-1,3-thiazol-5-yl]methyl]-n-[3-(1h-imidazol-2-yl)-2-phenyl-1-benzofuran-6-yl]methanesulfonamide Chemical compound C=1C=C2C(C=3NC=CN=3)=C(C=3C=CC=CC=3)OC2=CC=1N(S(=O)(=O)C)CC=1SC(Br)=NC=1C(F)(F)F SNCMKFLBEGDPQR-UHFFFAOYSA-N 0.000 claims 1
- VULCXZDDYRPAAH-UHFFFAOYSA-N n-benzyl-n-[3-(1h-imidazol-2-yl)-2-phenyl-1-benzofuran-6-yl]methanesulfonamide Chemical compound C=1C=C2C(C=3NC=CN=3)=C(C=3C=CC=CC=3)OC2=CC=1N(S(=O)(=O)C)CC1=CC=CC=C1 VULCXZDDYRPAAH-UHFFFAOYSA-N 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 229910000027 potassium carbonate Inorganic materials 0.000 claims 1
- 238000010992 reflux Methods 0.000 claims 1
- 230000010076 replication Effects 0.000 claims 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 1
- 125000000464 thioxo group Chemical group S=* 0.000 claims 1
- 230000029812 viral genome replication Effects 0.000 claims 1
- 0 CC1NC(*)(*2=CC2)O*1 Chemical compound CC1NC(*)(*2=CC2)O*1 0.000 description 4
- UCGULTOLGVOAGE-UHFFFAOYSA-N Nc1c(C(I)=O)c(cc(c(N)c2)I)c2[o]1 Chemical compound Nc1c(C(I)=O)c(cc(c(N)c2)I)c2[o]1 UCGULTOLGVOAGE-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201061426312P | 2010-12-22 | 2010-12-22 | |
| US61/426,312 | 2010-12-22 | ||
| PCT/US2011/065558 WO2012087833A1 (en) | 2010-12-22 | 2011-12-16 | Hepatitis c inhibitors and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014500322A JP2014500322A (ja) | 2014-01-09 |
| JP2014500322A5 true JP2014500322A5 (OSRAM) | 2015-02-12 |
| JP5918264B2 JP5918264B2 (ja) | 2016-05-18 |
Family
ID=45476645
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013546262A Expired - Fee Related JP5918264B2 (ja) | 2010-12-22 | 2011-12-16 | Ｃ型肝炎阻害剤およびその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US9173887B2 (OSRAM) |
| EP (1) | EP2655362A1 (OSRAM) |
| JP (1) | JP5918264B2 (OSRAM) |
| CN (2) | CN106986862A (OSRAM) |
| CA (1) | CA2822357A1 (OSRAM) |
| WO (1) | WO2012087833A1 (OSRAM) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9303020B2 (en) * | 2012-02-08 | 2016-04-05 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
| WO2014167008A1 (en) | 2013-04-12 | 2014-10-16 | Bayer Cropscience Ag | Novel triazolinthione derivatives |
| JP6397483B2 (ja) | 2013-04-12 | 2018-09-26 | バイエル・クロップサイエンス・アクチェンゲゼルシャフト | 新規トリアゾール誘導体 |
| CA2909213A1 (en) | 2013-04-12 | 2014-10-16 | Bayer Cropscience Aktiengesellschaft | Novel triazole derivatives |
| PL3043803T3 (pl) | 2013-09-11 | 2022-11-07 | Emory University | Kompozycje nukleotydowe i nukleozydowe oraz ich zastosowanie |
| GB201321733D0 (en) * | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic agents |
| JP2018511608A (ja) | 2015-04-02 | 2018-04-26 | バイエル・クロップサイエンス・アクチェンゲゼルシャフト | 殺真菌剤としてのトリアゾール誘導体 |
| EA201792151A1 (ru) | 2015-04-02 | 2018-04-30 | Байер Кропсайенс Акциенгезельшафт | Новые 5-замещенные производные имидазола |
| US11192914B2 (en) | 2016-04-28 | 2021-12-07 | Emory University | Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto |
| JP2019534860A (ja) | 2016-09-13 | 2019-12-05 | バイエル・クロップサイエンス・アクチェンゲゼルシャフト | ５−置換イミダゾール誘導体を含む活性化合物組合せ |
| BR112019006450A2 (pt) | 2016-09-29 | 2019-06-25 | Bayer Cropscience Ag | novos derivados de imidazolilmetila substituídos na posição 5 |
| EP3519392A1 (en) | 2016-09-29 | 2019-08-07 | Bayer CropScience Aktiengesellschaft | Novel 5-substituted imidazole derivatives |
| WO2018060075A1 (en) | 2016-09-29 | 2018-04-05 | Bayer Cropscience Aktiengesellschaft | 1 -[2-(1 -chlorocyclopropyl)-2-hydroxy-3-(3-phenyl-1,2-oxazol-5-yl)propyl]-1h-imidazole-5-carbonitrile derivatives and related compounds as fungicides for crop protection |
| JP7065951B2 (ja) | 2017-09-22 | 2022-05-12 | ジュビラント エピパッド エルエルシー | Ｐａｄ阻害剤としての複素環式化合物 |
| WO2019077631A1 (en) | 2017-10-18 | 2019-04-25 | Jubilant Biosys Limited | IMIDAZO-PYRIDINE COMPOUNDS FOR USE AS PAD INHIBITORS |
| EP3707135A1 (en) | 2017-11-06 | 2020-09-16 | Jubilant Prodel LLC | Pyrimidine derivatives as inhibitors of pd1/pd-l1 activation |
| US11213031B2 (en) | 2017-11-13 | 2022-01-04 | Bayer Aktiengesellschaft | Tetrazolylpropyl derivatives and their use as fungicides |
| IL274762B2 (en) | 2017-11-24 | 2023-10-01 | Jubilant Episcribe Llc | Novel heterocyclic compounds as prmt5 inhibitors |
| WO2019175897A1 (en) | 2018-03-13 | 2019-09-19 | Jubilant Biosys Limited | Bicyclic compounds as inhibitors of pd1/pd-l1 interaction/activation |
Family Cites Families (184)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3497597A (en) | 1967-08-01 | 1970-02-24 | American Cyanamid Co | Fungicidal composition and method containing 5-nitro-1,3,4-thiadiazoles |
| DE3208437A1 (de) | 1982-03-09 | 1983-09-15 | Bayer Ag, 5090 Leverkusen | Imidazothiadiazolalkencarbonsaeureamide, neue zwischenprodukte zu ihrer herstellung, ihre herstellung und ihre verwendung in arzneimitteln |
| SE8704248D0 (sv) | 1987-10-30 | 1987-10-30 | Haessle Ab | Medical use |
| AU6355190A (en) | 1989-06-13 | 1991-01-17 | Smithkline Beecham Corporation | Inhibition of interleukin-1 and tumor necrosis factor production by monocytes and/or macrophages |
| JP2778009B2 (ja) | 1989-09-12 | 1998-07-23 | 株式会社リコー | 電子写真感光体 |
| US5716964A (en) | 1989-12-04 | 1998-02-10 | G.D. Searle & Co. | Tetrazolyl substituted imidazo 1,2-a!pyridinylalkyl compounds for treatment of neurotoxic injury |
| KR910011852A (ko) | 1989-12-04 | 1991-08-07 | 폴 디. 매튜카이티스 | 신경독 장해 치료용 이미다조[1,2-a]피리디닐알킬 화합물 |
| KR930700104A (ko) | 1990-06-12 | 1993-03-13 | 원본미기재 | 5-리프옥시게나제 및 사이클로옥시게나제 경로 개재된 질병의 억제 |
| EP0550631B1 (en) | 1990-09-25 | 1997-01-02 | Rhone-Poulenc Rorer International (Holdings) Inc. | Compounds having antihypertensive and anti-ischemic properties |
| GB9026926D0 (en) | 1990-12-12 | 1991-01-30 | Smith Kline French Lab | Novel process |
| AU9137591A (en) | 1990-12-13 | 1992-07-08 | Smithkline Beecham Corporation | Novel csaids |
| WO1992010498A1 (en) | 1990-12-13 | 1992-06-25 | Smithkline Beecham Corporation | Novel csaids |
| US5240943A (en) | 1991-12-19 | 1993-08-31 | G. D. Searle & Co. | Benzopyran class iii antiarrhythmic agents |
| WO1993025205A1 (en) | 1992-06-10 | 1993-12-23 | Fujisawa Pharmaceutical Co., Ltd. | Pyrazolopyridine compounds for the treatment of anemia |
| WO1994001415A1 (fr) | 1992-07-03 | 1994-01-20 | Kumiai Chemical Industry Co., Ltd. | Derive heterocyclique condense et desherbant |
| US5317028A (en) | 1992-09-08 | 1994-05-31 | Warner-Lambert Co. | 7-((substituted)amino)-8((substituted)carbonyl)-methylamino-1-oxaspiro(4,5)decanes useful in Parkinson's disease, dystonia, and other movement disorders |
| TW253885B (OSRAM) | 1992-12-15 | 1995-08-11 | Ishihara Sangyo Kaisha | |
| WO1994021615A1 (en) | 1993-03-18 | 1994-09-29 | Merck Sharp & Dohme Limited | Benzimidazole derivatives |
| GB9316890D0 (en) | 1993-08-13 | 1993-09-29 | Pilkington Plc | Photochromic compounds |
| GB9408577D0 (en) | 1994-04-29 | 1994-06-22 | Fujisawa Pharmaceutical Co | New compound |
| JPH10513151A (ja) | 1994-12-22 | 1998-12-15 | バイオケム ファーマ インコーポレイテッド | トロンビン阻害剤としての複素環式ケトアルギニンペプチド |
| WO1996033715A1 (en) | 1995-04-27 | 1996-10-31 | Fujisawa Pharmaceutical Co., Ltd. | Novel use of pyrazolopyridine compounds |
| WO1996034866A1 (en) | 1995-05-01 | 1996-11-07 | Fujisawa Pharmaceutical Co., Ltd. | Imidazo 1,2-a pyridine and imidazo 1,2-a pyridezine derivatives and their use as bone resorption inhibitors |
| FR2735774B1 (fr) | 1995-06-21 | 1997-09-12 | Sanofi Sa | Utilisation de composes agonistes du recepteur cb2 humain pour la preparation de medicaments immunomodulateurs, nouveaux composes agonistes du recepteur cb2 et les compositions pharmaceutiques les contenant |
| GB9519077D0 (en) | 1995-09-18 | 1995-11-15 | Fujisawa Pharmaceutical Co | New heterocyclic compounds |
| DE19547263C2 (de) | 1995-12-07 | 1999-04-29 | Cardiotec Inc | Amidinohydrazone vom Benzo[b]furan abgeleiteter Ketone, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| WO1997027190A1 (en) | 1996-01-22 | 1997-07-31 | Fujisawa Pharmaceutical Co., Ltd. | Thiazolylbenzofuran derivatives and pharmaceutical compositions containing them |
| WO1997027204A1 (en) | 1996-01-23 | 1997-07-31 | The Regents Of The University Of Michigan | Modified benzimidazole nucleosides as antiviral agents |
| JP3995716B2 (ja) | 1996-03-18 | 2007-10-24 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 縮合環含有カルボン酸誘導体 |
| WO1997040047A1 (en) | 1996-04-25 | 1997-10-30 | Fujisawa Pharmaceutical Co., Ltd. | Preventives and remedies for ischemic intestinal lesion and ileus |
| GB9610813D0 (en) | 1996-05-23 | 1996-07-31 | Pharmacia Spa | Combinatorial solid phase synthesis of a library of benzufuran derivatives |
| IL127261A0 (en) | 1996-06-17 | 1999-09-22 | American Home Prod | Heterocyclylmethylamino derivatives of cyclobutene-3,4- diones as potassium channel modulators |
| DE19624289A1 (de) | 1996-06-18 | 1998-01-02 | Merckle Gmbh | Pyrrolizin-Verbindungen und deren Verwendung |
| WO1998001428A1 (en) | 1996-07-08 | 1998-01-15 | Du Pont Pharmaceuticals Company | AMIDINOINDOLES, AMIDINOAZOLES, AND ANALOGS THEREOF AS INHIBITORS OF FACTOR Xa AND OF THROMBIN |
| ES2186916T3 (es) | 1996-08-21 | 2003-05-16 | Upjohn Co | Derivados de isoxazolina como agentes antimicrobianos. |
| WO1998039342A1 (en) | 1997-03-07 | 1998-09-11 | Metabasis Therapeutics, Inc. | Novel indole and azaindole inhibitors of fructose-1,6-bisphosphatase |
| EP0972525A4 (en) | 1997-03-18 | 2000-11-29 | Fujisawa Pharmaceutical Co | PREVENTIVE AND HEALING AGENTS AGAINST HYPERPHOSPHATEMIA |
| US6255304B1 (en) | 1997-05-30 | 2001-07-03 | Pharmacia & Upjohn Company | Oxazolidinone antibacterial agents having a thiocarbonyl functionality |
| NZ501412A (en) | 1997-05-30 | 2001-11-30 | Upjohn Co | Oxazolidinone antibacterial agents having a thiocarbonyl functionality |
| US7008950B1 (en) | 1997-06-05 | 2006-03-07 | Takeda Chemical Industries, Ltd. | Benzofurans as suppressors of neurodegeneration |
| US5998424A (en) | 1997-06-19 | 1999-12-07 | Dupont Pharmaceuticals Company | Inhibitors of factor Xa with a neutral P1 specificity group |
| GB9716244D0 (en) | 1997-07-31 | 1997-10-08 | Electrophoretics International | Pharmaceutical compounds |
| US6080773A (en) | 1997-10-14 | 2000-06-27 | Akzo Nobel, N.V. | Benzylamine derivatives which are useful in treating psychiatric disorders |
| US6630597B1 (en) | 1997-12-15 | 2003-10-07 | Transitions Optical, Inc. | Photochromic 6-aryl substituted 3H-naphtho(2,1-b)pyrans |
| US6262044B1 (en) | 1998-03-12 | 2001-07-17 | Novo Nordisk A/S | Modulators of protein tyrosine phosphatases (PTPASES) |
| WO1999059999A1 (en) | 1998-05-21 | 1999-11-25 | Shionogi & Co., Ltd. | PYRROLO[1,2-b]PYRIDAZINE DERIVATIVES HAVING sPLA2 INHIBITORY EFFECT |
| EP1084710B1 (en) | 1998-06-01 | 2006-10-18 | Astellas Pharma Inc. | Adenosine a1 antagonists for male sterility |
| US6362371B1 (en) | 1998-06-08 | 2002-03-26 | Advanced Medicine, Inc. | β2- adrenergic receptor agonists |
| US6410562B1 (en) | 1998-12-18 | 2002-06-25 | Eli Lilly And Company | Hypoglycemic imidazoline compounds |
| JP2001057292A (ja) | 1999-08-20 | 2001-02-27 | Toray Ind Inc | 発光素子 |
| CA2388189A1 (en) | 1999-10-19 | 2001-04-26 | Menbrane Extraction Technology Limited | Process for removing and recovering of phenolic compounds from aqueous fluids |
| JP2001139575A (ja) | 1999-11-15 | 2001-05-22 | Fujisawa Pharmaceut Co Ltd | 新規ピラゾロピリジン誘導体 |
| US6461538B2 (en) | 1999-12-16 | 2002-10-08 | Fuji Photo Film Co., Ltd. | Production process for indolizine compounds and their use in organic light-emitting devices |
| US6403588B1 (en) | 2000-04-27 | 2002-06-11 | Yamanouchi Pharmaceutical Co., Ltd. | Imidazopyridine derivatives |
| ES2244613T3 (es) | 2000-04-27 | 2005-12-16 | Astellas Pharma Inc. | Derivados de imidazopiridina. |
| GB0017676D0 (en) * | 2000-07-19 | 2000-09-06 | Angeletti P Ist Richerche Bio | Inhibitors of viral polymerase |
| ATE301653T1 (de) | 2000-12-15 | 2005-08-15 | Glaxo Group Ltd | Pyrazolopyridine |
| DE10117183A1 (de) | 2001-04-05 | 2002-10-10 | Gruenenthal Gmbh | Verwendung von substituierten Imidazo[1,2-a]-pyridinverbindungen als Arzneimittel |
| NZ529043A (en) | 2001-04-16 | 2006-11-30 | Tanabe Seiyaku Co | Large conductance calcium-activated K channel opener |
| CA2452596C (en) | 2001-07-05 | 2010-12-21 | Takeda Chemical Industries, Ltd. | Benzo-fused 5-membered heterocyclic compounds, their production and use |
| HUP0401283A2 (hu) | 2001-08-30 | 2004-12-28 | Merckle Gmbh | Annellált pirrolvegyületek alkalmazása ízületi porc vagy porc melletti csont elfajulásának kezelésére, és ezeket tartalmazó gyógyszerkészítmények |
| CN100347158C (zh) | 2001-10-25 | 2007-11-07 | 旭化成制药株式会社 | 二环化合物 |
| US20050113283A1 (en) | 2002-01-18 | 2005-05-26 | David Solow-Cordero | Methods of treating conditions associated with an EDG-4 receptor |
| TW200930291A (en) | 2002-04-29 | 2009-07-16 | Bayer Cropscience Ag | Pesticidal heterocycles |
| MY140680A (en) | 2002-05-20 | 2010-01-15 | Bristol Myers Squibb Co | Hepatitis c virus inhibitors |
| WO2004014908A1 (en) | 2002-08-13 | 2004-02-19 | Warner-Lambert Company Llc | Heterobicylcic metalloproteinase inhibitors |
| US6828044B2 (en) | 2002-10-25 | 2004-12-07 | Eastman Kodak Company | Dopant in an electroluminescent device |
| WO2004041201A2 (en) | 2002-11-01 | 2004-05-21 | Viropharma Incorporated | Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |
| US7098231B2 (en) | 2003-01-22 | 2006-08-29 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
| ATE445618T1 (de) | 2003-02-27 | 2009-10-15 | Neurosearch As | Neue diazabicyclische arylderivate |
| US7872014B2 (en) | 2003-07-23 | 2011-01-18 | Exelixis, Inc. | Anaplastic lymphoma kinase modulators and methods of use |
| ATE487475T1 (de) | 2003-08-01 | 2010-11-15 | Chugai Pharmaceutical Co Ltd | Heterocyclische verbindungen als nützliche malonyl-coa decarboxylase-hemmer |
| WO2005014543A1 (ja) | 2003-08-06 | 2005-02-17 | Japan Tobacco Inc. | 縮合環化合物及びそのｈｃｖポリメラーゼ阻害剤としての利用 |
| US7538120B2 (en) | 2003-09-03 | 2009-05-26 | Array Biopharma Inc. | Method of treating inflammatory diseases |
| US7144907B2 (en) | 2003-09-03 | 2006-12-05 | Array Biopharma Inc. | Heterocyclic inhibitors of MEK and methods of use thereof |
| US7351726B2 (en) | 2003-09-25 | 2008-04-01 | Wyeth | Substituted oxadiazolidinediones |
| EP1663199B1 (en) | 2003-09-25 | 2013-04-03 | Tel Aviv University Future Technology Development L.P. | Compositions and methods using same for treating amyloid-associated diseases |
| US7288638B2 (en) | 2003-10-10 | 2007-10-30 | Bristol-Myers Squibb Company | Fully human antibodies against human 4-1BB |
| WO2005037223A2 (en) | 2003-10-15 | 2005-04-28 | Brigham And Women's Hospital, Inc. | Methods and compositions for immunomodulation |
| SE0303480D0 (sv) | 2003-12-19 | 2003-12-19 | Biovitrum Ab | Benzofuranes |
| WO2005066151A2 (en) | 2003-12-19 | 2005-07-21 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
| US7229480B2 (en) | 2004-02-13 | 2007-06-12 | The Procter & Gamble Company | Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof |
| US20050256150A1 (en) | 2004-02-20 | 2005-11-17 | Vladimir Birman | Enantioselective acyl transfer catalysts and their use in kinetic resolution of alcohols and desymmetrization of meso-diols |
| US7306631B2 (en) | 2004-03-30 | 2007-12-11 | The Procter & Gamble Company | Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof |
| EP1746888A2 (en) | 2004-05-13 | 2007-01-31 | Viropharma Incorporated | Compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |
| PE20060619A1 (es) | 2004-07-29 | 2006-07-11 | Ferrer Int | Derivados de oxazolidinona como antibacterianos |
| GB0420719D0 (en) | 2004-09-17 | 2004-10-20 | Addex Pharmaceuticals Sa | Novel allosteric modulators |
| AU2005318596B2 (en) | 2004-12-21 | 2010-12-23 | F. Hoffmann-La Roche Ag | Chroman derivatives and their use as 5-HT receptor ligands |
| US7666880B2 (en) | 2005-03-21 | 2010-02-23 | S*Bio Pte Ltd. | Imidazo[1,2-A]pyridine derivatives: preparation and pharmaceutical applications |
| DE102005019181A1 (de) | 2005-04-25 | 2006-10-26 | Novartis Ag | Peptid-Deformylase (PDF) Inhibitoren 1 |
| MY148644A (en) | 2005-07-18 | 2013-05-15 | Orion Corp | New pharmaceutical compounds |
| US7825154B2 (en) | 2005-08-12 | 2010-11-02 | The United States Of America As Represented By The Secretary Of The Army | Small molecule inhibitors of botulinum neurotoxins |
| US7399758B2 (en) | 2005-09-12 | 2008-07-15 | Meanwell Nicholas A | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
| US7473688B2 (en) | 2005-09-13 | 2009-01-06 | Bristol-Myers Squibb Company | Indolobenzazepine HCV NS5B inhibitors |
| US7901793B2 (en) | 2005-09-23 | 2011-03-08 | Samsung Mobile Display Co., Ltd. | Organic light-emitting compound and organic light-emitting device containing the same |
| US7772183B2 (en) | 2005-10-12 | 2010-08-10 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US7741281B2 (en) | 2005-11-03 | 2010-06-22 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| PL2090575T3 (pl) | 2005-11-15 | 2011-09-30 | Array Biopharma Inc | Sposoby i związki pośrednie do otrzymywania pochodnych N4-fenylo-chinazolino-4-aminy |
| WO2007081630A2 (en) | 2005-12-21 | 2007-07-19 | Janssen Pharmaceutica, N.V. | Substituted pyrimidinyl kinase inhibitors |
| JP2009523729A (ja) * | 2006-01-13 | 2009-06-25 | ピーティーシー セラピューティクス，インコーポレーテッド | Ｃ型肝炎の治療方法 |
| EP1984375A2 (en) | 2006-01-25 | 2008-10-29 | Smithkline Beecham Corporation | Chemical compounds |
| US7456165B2 (en) | 2006-02-08 | 2008-11-25 | Bristol-Myers Squibb Company | HCV NS5B inhibitors |
| WO2007113226A1 (en) | 2006-03-31 | 2007-10-11 | Novartis Ag | Organic compounds |
| US7456166B2 (en) | 2006-05-17 | 2008-11-25 | Bristol-Myers Squibb Company | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
| US7521443B2 (en) | 2006-05-17 | 2009-04-21 | Bristol-Myers Squibb Company | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
| US7521441B2 (en) | 2006-05-22 | 2009-04-21 | Bristol-Myers Squibb Company | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
| US7521442B2 (en) | 2006-05-25 | 2009-04-21 | Bristol-Myers Squibb Company | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
| CN101490054B (zh) | 2006-05-25 | 2012-05-16 | 百时美施贵宝公司 | 环丙基稠合的吲哚并苯并氮杂*hcv ns5b抑制剂 |
| BRPI0712381A2 (pt) | 2006-06-06 | 2012-07-10 | Avigen Inc | compostos de pirazolo[1,5-a]piridina substituìda e seus métodos de uso |
| US7452876B2 (en) | 2006-06-08 | 2008-11-18 | Bristol-Myers Squibb Company | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
| US7935670B2 (en) | 2006-07-11 | 2011-05-03 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| MX2009000513A (es) * | 2006-07-14 | 2009-03-09 | Genelabs Tech Inc | Agentes antivirales. |
| US20090215818A1 (en) | 2006-07-24 | 2009-08-27 | Smithkline Beecham Corporation | Thiozolidinedione derivatives as pi3 kinase inhibitors |
| US20100158862A1 (en) | 2006-08-11 | 2010-06-24 | Bristol-Myers Squibb Company | Hepatitis C Virus Inhibitors |
| US8303944B2 (en) | 2006-08-11 | 2012-11-06 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US7759495B2 (en) | 2006-08-11 | 2010-07-20 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US7745636B2 (en) | 2006-08-11 | 2010-06-29 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US7659270B2 (en) | 2006-08-11 | 2010-02-09 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US8329159B2 (en) | 2006-08-11 | 2012-12-11 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US7790741B2 (en) | 2006-10-06 | 2010-09-07 | Abbott Laboratories | Imidazothiazoles and imidazoxazoles |
| US20080107625A1 (en) | 2006-11-01 | 2008-05-08 | Bristol-Myers Squibb Company | Inhibitors of Hepatitis C Virus |
| US8343477B2 (en) | 2006-11-01 | 2013-01-01 | Bristol-Myers Squibb Company | Inhibitors of hepatitis C virus |
| US20080107623A1 (en) | 2006-11-01 | 2008-05-08 | Bristol-Myers Squibb Company | Inhibitors of Hepatitis C Virus |
| US7994190B2 (en) | 2006-11-01 | 2011-08-09 | Bristol-Myers Squibb Company | Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
| US7772180B2 (en) | 2006-11-09 | 2010-08-10 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US7888464B2 (en) | 2006-11-16 | 2011-02-15 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US7763584B2 (en) | 2006-11-16 | 2010-07-27 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US8003604B2 (en) | 2006-11-16 | 2011-08-23 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| CN101195597A (zh) | 2006-12-08 | 2008-06-11 | 中国科学院上海药物研究所 | 1-取代-4,4-二取代氨基硫脲类化合物、其制备方法以及其用途 |
| US7541351B2 (en) | 2007-01-11 | 2009-06-02 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
| US7999001B2 (en) | 2007-01-15 | 2011-08-16 | The United States Of America As Represented By The Secretary Of The Army | Antiviral compounds and methods of using thereof |
| US7541352B2 (en) | 2007-02-02 | 2009-06-02 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
| US7517872B2 (en) | 2007-02-22 | 2009-04-14 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
| US7998951B2 (en) | 2007-03-05 | 2011-08-16 | Bristol-Myers Squibb Company | HCV NS5B inhibitors |
| US7538102B2 (en) | 2007-03-14 | 2009-05-26 | Bristol-Myers Squibb Company | Compounds for the treatment of Hepatitis C |
| US7541353B2 (en) | 2007-03-14 | 2009-06-02 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
| EP1972628A1 (en) | 2007-03-21 | 2008-09-24 | Schwarz Pharma Ag | Indolizines and aza-analog derivatives thereof as CNS active compounds |
| GB0707000D0 (en) | 2007-04-12 | 2007-05-30 | Istituto Di Ricerche D Biolog | Antiviral agents |
| WO2008134553A1 (en) | 2007-04-26 | 2008-11-06 | Xenon Pharmaceuticals Inc. | Methods of using bicyclic compounds in treating sodium channel-mediated diseases |
| US7741347B2 (en) | 2007-05-17 | 2010-06-22 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| WO2008154241A1 (en) | 2007-06-08 | 2008-12-18 | Abbott Laboratories | 5-heteroaryl substituted indazoles as kinase inhibitors |
| TW200916098A (en) | 2007-06-14 | 2009-04-16 | Teijin Pharma Ltd | Agent for lowering uric acid level |
| US7652004B2 (en) | 2007-08-09 | 2010-01-26 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
| US8143243B2 (en) | 2007-08-09 | 2012-03-27 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
| SI2193133T1 (sl) | 2007-09-27 | 2015-12-31 | Fundacion Centro Nacional De Investigaciones Oncologicas Carlos Iii | Imidazolotiadiazoli za uporabo kot zaviralci protein-kinaze |
| US8124601B2 (en) | 2007-11-21 | 2012-02-28 | Bristol-Myers Squibb Company | Compounds for the treatment of Hepatitis C |
| US8129367B2 (en) | 2007-11-21 | 2012-03-06 | Bristol-Myers Squibb Company | Compounds for the treatment of Hepatitis C |
| CA2715400A1 (en) | 2008-02-12 | 2009-08-20 | Bristol-Myers Squibb Company | Heterocyclic derivatives as hepatitis c virus inhibitors |
| US8147818B2 (en) | 2008-02-13 | 2012-04-03 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US7704992B2 (en) | 2008-02-13 | 2010-04-27 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| CA2714254A1 (en) | 2008-02-14 | 2009-08-20 | F. Hoffmann-La Roche Ag | Heterocyclic antiviral compounds |
| KR100929642B1 (ko) | 2008-02-20 | 2009-12-03 | 주식회사 하이닉스반도체 | 반도체 소자 및 그의 제조방법 |
| JP2009203203A (ja) | 2008-02-29 | 2009-09-10 | Toyo Ink Mfg Co Ltd | アントラセン誘導体及びその用途 |
| EP2282742A1 (en) | 2008-04-09 | 2011-02-16 | Infinity Pharmaceuticals, Inc. | Inhibitors of fatty acid amide hydrolase |
| GB0806656D0 (en) | 2008-04-11 | 2008-05-14 | Karobio Ab | Novel estrogen receptor ligands |
| US8163921B2 (en) | 2008-04-16 | 2012-04-24 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| JPWO2009128520A1 (ja) | 2008-04-18 | 2011-08-04 | 塩野義製薬株式会社 | Ｐｉ３ｋ阻害活性を有する複素環化合物 |
| EP2110374A1 (en) | 2008-04-18 | 2009-10-21 | Merck Sante | Benzofurane, benzothiophene, benzothiazol derivatives as FXR modulators |
| WO2009137500A1 (en) | 2008-05-05 | 2009-11-12 | Wyeth | 6-substituted benzofuran compounds to treat infection with hepatitis c virus |
| US8133884B2 (en) | 2008-05-06 | 2012-03-13 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
| US20090285773A1 (en) | 2008-05-15 | 2009-11-19 | Bristol-Myers Squibb Company | Hepatitis C Virus Inhibitors |
| US20090285774A1 (en) | 2008-05-15 | 2009-11-19 | Bristol-Myers Squibb Company | Hepatitis C Virus Inhibitors |
| JP5529120B2 (ja) | 2008-05-29 | 2014-06-25 | ブリストル−マイヤーズ スクイブ カンパニー | Ｃ型肝炎ウイルス阻害剤 |
| US7964560B2 (en) | 2008-05-29 | 2011-06-21 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| AR072008A1 (es) | 2008-06-13 | 2010-07-28 | Merck & Co Inc | Compuestos heterobiciclicos como agentes de inhibicion de quinasa p38 |
| EP2313102A2 (en) * | 2008-07-03 | 2011-04-27 | Biota Scientific Management | Bycyclic nucleosides and nucleotides as therapeutic agents |
| US7906655B2 (en) | 2008-08-07 | 2011-03-15 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US8453322B2 (en) | 2008-08-14 | 2013-06-04 | Ddi Global Corp. | Manufacturing methods of multilayer printed circuit board having stacked via |
| US20100056491A1 (en) | 2008-08-29 | 2010-03-04 | Memory Pharmaceuticals Corporation | 4'-amino cyclic compounds having 5-ht6 receptor affinity |
| US8198449B2 (en) * | 2008-09-11 | 2012-06-12 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
| US7994171B2 (en) | 2008-09-11 | 2011-08-09 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
| US8048887B2 (en) * | 2008-09-11 | 2011-11-01 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
| US8293909B2 (en) | 2008-09-11 | 2012-10-23 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
| US20120021519A1 (en) | 2008-09-19 | 2012-01-26 | Presidents And Fellows Of Harvard College | Efficient induction of pluripotent stem cells using small molecule compounds |
| US20100080770A1 (en) | 2008-09-29 | 2010-04-01 | Bristol-Myers Squibb Company | Hepatitis C Virus Inhibitors |
| US8563505B2 (en) | 2008-09-29 | 2013-10-22 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US8044087B2 (en) | 2008-09-29 | 2011-10-25 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US8383094B2 (en) | 2008-10-01 | 2013-02-26 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| JP5416944B2 (ja) | 2008-10-23 | 2014-02-12 | ユー・ディー・シー アイルランド リミテッド | 有機電界発光素子 |
| US8283310B2 (en) | 2008-12-15 | 2012-10-09 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US20100204265A1 (en) | 2009-02-09 | 2010-08-12 | Genelabs Technologies, Inc. | Certain Nitrogen Containing Bicyclic Chemical Entities for Treating Viral Infections |
| TWI438200B (zh) | 2009-02-17 | 2014-05-21 | 必治妥美雅史谷比公司 | Ｃ型肝炎病毒抑制劑 |
| TWI476190B (zh) | 2009-03-30 | 2015-03-11 | 必治妥美雅史谷比公司 | Ｃ型肝炎病毒抑制劑 |
| TW201038559A (en) | 2009-04-09 | 2010-11-01 | Bristol Myers Squibb Co | Hepatitis C virus inhibitors |
-
2011
- 2011-12-16 EP EP11808073.8A patent/EP2655362A1/en not_active Withdrawn
- 2011-12-16 US US13/995,701 patent/US9173887B2/en active Active
- 2011-12-16 WO PCT/US2011/065558 patent/WO2012087833A1/en not_active Ceased
- 2011-12-16 JP JP2013546262A patent/JP5918264B2/ja not_active Expired - Fee Related
- 2011-12-16 CN CN201610903761.7A patent/CN106986862A/zh active Pending
- 2011-12-16 CN CN201180068128.6A patent/CN103649079B/zh not_active Expired - Fee Related
- 2011-12-16 CA CA2822357A patent/CA2822357A1/en not_active Abandoned
-
2015
- 2015-09-14 US US14/852,984 patent/US9453007B2/en active Active
-
2016
- 2016-08-18 US US15/240,753 patent/US9567355B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014500322A5 (OSRAM) | ||
| AU2007213451B2 (en) | Treatment of Duchenne muscular dystrophy | |
| KR101345473B1 (ko) | 헤테로 화합물 | |
| US12458642B2 (en) | Metalloenzyme inhibitor compounds | |
| JP2020516671A5 (OSRAM) | ||
| JP2013532652A5 (OSRAM) | ||
| RU2008110949A (ru) | Соединения и композиции-иммуносупрессанты | |
| JP2017505762A5 (OSRAM) | ||
| JP2017523972A5 (OSRAM) | ||
| JP2009524670A5 (OSRAM) | ||
| RU2015111133A (ru) | Ингибиторы тирозинкиназы брутона | |
| RU2011116226A (ru) | Пиразолопиридиновые производные как ингибиторы надфн-оксидазы | |
| JP2014531449A5 (OSRAM) | ||
| JP2014525444A5 (OSRAM) | ||
| JP2007533635A5 (OSRAM) | ||
| RU2012107101A (ru) | Производные пирроло[1,2-в] пиридазина как ингибиторы янус-киназы | |
| ES2533095T3 (es) | Agonistas de receptores de esfingosina-1-fosfato | |
| JP2018507234A5 (OSRAM) | ||
| US9187437B2 (en) | Substituted oxadiazole compounds | |
| JP2013527847A5 (OSRAM) | ||
| JP2004525183A5 (OSRAM) | ||
| JP2019522628A5 (OSRAM) | ||
| WO2012061459A1 (en) | Heterocyclic compounds as s1p1 agonists for the treatment of autoimmune and vascular diseases | |
| JP2014513122A5 (OSRAM) | ||
| JP2010514733A5 (OSRAM) |